A synthetic molecule that blocks an enzyme to support cellular energy and shift fat cells toward burning rather than storing fuel. In obese mice it lowered weight and fat and improved muscle repair, but no human studies exist — no proven dose, benefit, or safety record. Sold only as an unapproved research chemical of uncertain purity. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting glucose | 75–90 mg/dL | Tracks proposed glucose-lowering effect |
| Fasting insulin | 2–5 µIU/mL | Detects insulin-sensitivity changes |
| HbA1c | <5.4% | Longer-term glucose control |
| ALT / AST | ALT <25 U/L; AST <25 U/L | Liver is a target tissue; watch for stress |
| Lipid panel (total/LDL/HDL/triglycerides) | Triglycerides <80 mg/dL; HDL >50 mg/dL | Mouse data showed cholesterol reduction |
| Homocysteine | <8 µmol/L | Mechanistic concern from SAH/homocysteine pathway |
Cadence: Baseline, then around 4–8 weeks, then every 3–6 months